NCT06306534
Recruiting
N/A
Intraoperative Acute Study to Evaluate Auditory Intranerve Stimulation
ConditionsAuditory; Nerve
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Auditory; Nerve
- Sponsor
- Hannover Medical School
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Elicit a typical eABR Wave V with at least 0.2 µV in amplitude and a latency of the peak around 5 ms
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This feasibility clinical investigation is designed to answer the question of whether auditory brainstem responses can be safely elicited by acute electrical stimulation within the human auditory nerve.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Written informed consent
- •Patients who will undergo an acoustic neuroma removal surgery and are functional deaf
- •Age ≥ 18 years
- •Women with childbearing potential: willingness to use a reliable contraceptive method (e.g. copper intrauterine devices or hormonal methods) after consulting their gyncecologists
Exclusion Criteria
- •Disabilities in addition to hearing impairment which might interfere with the study procedure
- •Pregnant and breast feeding woman or other vulnerable population
Outcomes
Primary Outcomes
Elicit a typical eABR Wave V with at least 0.2 µV in amplitude and a latency of the peak around 5 ms
Time Frame: 4 weeks
Secondary Outcomes
- Collection of adverse events(4 weeks)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
N/A
Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma SurgeryDeafnessNCT05248113University of California, Irvine8
Completed
N/A
AB-Intra- and Post-Operative Measures of Auditory FunctionHearing LossCochlear ImplantNCT03685461Medical College of Wisconsin88
Completed
N/A
Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic NeuromaHearing Loss, CochlearNeurinoma of the Acoustic NerveNCT02948790Oticon Medical17
Completed
Phase 1
An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 TumorsNeurofibromatosis 2NCT00030043FDA Office of Orphan Products Development10
Completed
N/A
Sounds Locked to ElectroEncephalogram Phase For the Acceleration of Sleep Onset TimeSleepSleep DisturbanceNCT05743114Elemind Technologies, Inc.200